Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer

NCT04340141 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT04340141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04340141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 13, 2020
Completion date
November 1, 2030
Enrollment
358 (actual)
Sites
453

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenosquamous carcinoma, resectable pancreatic adenocarcinoma, stage i pancreatic cancer ajcc v8, stage ii pancreatic cancer ajcc v8, stage iii pancreatic cancer ajcc v8